Scientific Project Director, Precancer Atlas, MD Anderson. Views are my own.
Photo credit to NCI's Cancer Close Up 2016, Ryan A. Denu, Carbone Cancer Center.
"Our vision is to develop this atlas so that we can identify actionable targets for intercepting pre-cancers,” says Eduardo Vilar-Sanchez, M.D., Ph.D., co-director of the Pre-Cancer Atlas project.
What if we could stop cancer before it causes harm?
That’s the goal of our Pre-Cancer Atlas project, co-led by Dr. Eduardo Vilar-Sanchez and Dr. Anirban Maitra: https://t.co/oi8X6DAc4v @evilarsan@Aiims1742#CancerMoonshot#EndCancer
@ppisters@MDAndersonNews Congratulations, Dr. Pisters! Thank you for your servant leadership & everything you've done to lead us thru the challenges of the pandemic!
Thank you @bcmhouston for so quickly getting shots into the arms of kids under 16. 4 of us vaxxed, just 1 more to go. C'mon Pfizer & the FDA! Get that approval for elementary school kids before August!
Congrats to @evilarsan on inclusion in NCI's "champions and changemakers of cancer prevention, early detection and symptom science." Proud to be working with you as part of the PCA! ☺️ https://t.co/xYPtfevkjN
Nice lay explanation for tumor microenv. Like the yard (microenv) & house (tumor) analogy. @MDAndersonNews PCA focuses on role of immune cells in "yard" & how they contribute to different types of developing "houses".
https://t.co/16u5LX3FTv
Congrats to Dr. Navin, Dr. Ludford & Dr. Amit! We are fortunate to have @nicholas_navin leading single cell sequencing efforts of the @MDAndersonNews Precancer Atlas! #EndCancer
Congratulations to our Dr. Nicholas Navin, Dr. Kaysia Ludford and Dr. Moran Amit for being recognized by AACR for achievements in cancer research.
Learn about their work being shared this week at #AACR21: https://t.co/Nyr8v3fsE7 @AACR@nicholas_navin@DraettaG#EndCancer
Follow @MDA_PCA for the latest news & progress on @MDAndersonNews 's Precancer Atlas led by @evilarsan & @Aiims1742. Collab with @nicholas_navin@kchenken Dr. Jianjun Zhang & Dr. Melinda Yates to discover immune biomarkers & agents to intercept cancer in its earliest stages!